• Explore /
  • Poster
  • / A pilot safety study of gemcitabine and cisplatin (GC) with atezolizumab (A) as first-line therapy in patients (pts) with metastatic urothelial cancer (mUC).

A pilot safety study of gemcitabine and cisplatin (GC) with atezolizumab (A) as first-line therapy in patients (pts) with metastatic urothelial cancer (mUC).

Abstract Poster

Authors

null

Samuel Aaron Funt

Memorial Sloan Kettering Cancer Center, New York, NY

Samuel Aaron Funt , karan jatwani , Michelle Makris , Ashley Marie Regazzi , Chung-Han Lee , Min Yuen Teo , Deaglan Joseph McHugh , Asia S. McCoy , Grace Hettich , Phillip Wong , Moshen Abu-Akeel , Jedd D. Wolchok , Taha Merghoub , Hikmat Al-Ahmadie , Irina Ostrovnaya , Joshua Chaim , Jeremy C. Durack , Gopa Iyer , Dean F. Bajorin , Jonathan E. Rosenberg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Bladder Cancer

Clinical Trial Registration Number

NCT02989584

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4559)

DOI

10.1200/JCO.2019.37.15_suppl.4559

Abstract #

4559

Poster Bd #

385

Abstract Disclosures

Similar Posters

First Author: Samuel Aaron Funt

First Author: John Ebben

First Author: Panpan Zhang

First Author: Michael Lattanzi